Laxxon Medical

Laxxon is a pharma-technology company pioneering a new generation of advanced pharmaceuticals with SPID, a novel 3D screen printing platform technology. From common pharmaceutical drugs to new drug developments, SPID unlocks innovative drug delivery advancements paired with fast-tracked market access and extensive IP protection to yield disruptive opportunities for partners, healthcare providers, and patients. Laxxons diverse product pipeline is continuously growing and consists of 13 in-house Advanced Patented Generics, in addition to multiple ongoing working-projects with notable pharmaceutical players, biotech organizations and research universities

Advanced patented generics,patent extension,technology transfer,research & development,commercialization,new drug development,3d screen printing,additive manufacturing,505(b)(2),heterogeneous distribution,sequential release,and co-development

Laxxon medical operates in the Pharmaceutical manufacturing industry.

Laxxon medical's revenue is 11m - 100m

Laxxon medical has 11 - 50 employees.